Clinical Trial Update: Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating ACU-D1 for HPV-related vulvar and perianal lesions in people with HIV. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Intraepithelial Neoplasia
• HIV Infection
• High-grade Squamous Intraepithelial Lesions
• Human Papillomavirus Infection
• Vulvar Intraepithelial Neoplasia

Drugs mentioned

• ACU-D1

Snippet

Sponsor: Emory University | Conditions: Human Papilloma Virus, Human Immunodeficiency Virus | Phase 1 | Status: NOT_YET_RECRUITING